Benzyl 3-hydroxypiperidine-1-carboxylate

Catalog No.: 
ACPAKV530
CAS No.: 
95798-22-4
Molecular Formula: 
C13H17NO3
Molecular Weight: 
235.28
Benzyl 3-hydroxypiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$92.00In stockInquiry
500g98%$451.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 3-hydroxypiperidine-1-carboxylate
IUPAC Namebenzyl 3-hydroxypiperidine-1-carboxylate
MDL No.MFCD03839903
Molecular FormulaC13H17NO3
Molecular Weight235.28
SMILESO=C(N1CC(O)CCC1)OCC2=CC=CC=C2
InChI KeyNDGWBAFATMSBHZ-UHFFFAOYSA-N
SynonymMFCD11112281 | 1-cbz-3-hydroxy-piperidine | R-1-CBZ-3-Hydroxy-piperidine | 1-N-CBZ-3-HYDRoxypipERIDINE | 1-N-Cbz-3-hydroxy-piperidine | MFCD11112280 | n-cbz-3-hydroxypiperidine | MFCD03839903 | benzyl 3-hydroxypiperidine-1-carboxylate | S-1-CBZ-3-Hydroxy-
CAS No.95798-22-4
PubChem CID561665

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPAKV530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMBNV142 route compound structure diagram
    ACMBNV14261995-20-8In Stock
  2. Then
  3. ACPAKV530 route product structure diagram
    ACPAKV53095798-22-4In Stock
Inquiry

2. ACPAKV530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPAKV530 route product structure diagram
    ACPAKV53095798-22-4In Stock
Inquiry

3. ACPAKV530 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPAKV530 route product structure diagram
    ACPAKV53095798-22-4In Stock
Inquiry

Comments (0)